In a study among 45 789 cases from the Scottish Cancer Registry, Gray et al. (8) found that among women with estrogen receptor–positive diseases, the predicted 5-year mortality was only 0.5% greater than the observed one, and the AUC was 0.76. This evidence concerns the gene ESR1 and cancer.